In 2025, AstraZeneca's Nexium generated *** million U.S. dollars in revenue; a gradual decline was seen over the years. AstraZeneca plc is one of the major pharmaceutical companies worldwide (based on Rx drug revenue). The multinational company is headquartered in London, UK. AstraZeneca is focused on products for the following major disease areas: cancer, cardiovascular, gastrointestinal, infectious diseases, neuroscience, respiratory, and inflammation.Â
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
AstraZeneca, & U.S. Securities and Exchange Commission. (February 18, 2026). Revenue of AstraZeneca's product Nexium from 2006 to 2025 (in million U.S. dollars) [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 30, 2026, from /statistics/266545/astrazenecas-revenue-from-top-product-nexium-since-2006/
AstraZeneca, und U.S. Securities and Exchange Commission. "Revenue of AstraZeneca's product Nexium from 2006 to 2025 (in million U.S. dollars)." Chart. February 18, 2026. ÌÇÐÄÆƽâ°æ. Accessed July 30, 2026. /statistics/266545/astrazenecas-revenue-from-top-product-nexium-since-2006/
AstraZeneca, U.S. Securities and Exchange Commission. (2026). Revenue of AstraZeneca's product Nexium from 2006 to 2025 (in million U.S. dollars). ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 30, 2026. /statistics/266545/astrazenecas-revenue-from-top-product-nexium-since-2006/
AstraZeneca, and U.S. Securities and Exchange Commission. "Revenue of Astrazeneca's Product Nexium from 2006 to 2025 (in Million U.S. Dollars)." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 18 Feb 2026, /statistics/266545/astrazenecas-revenue-from-top-product-nexium-since-2006/
AstraZeneca & U.S. Securities and Exchange Commission, Revenue of AstraZeneca's product Nexium from 2006 to 2025 (in million U.S. dollars) ÌÇÐÄÆƽâ°æ, /statistics/266545/astrazenecas-revenue-from-top-product-nexium-since-2006/ (last visited July 30, 2026)
Revenue of AstraZeneca's product Nexium from 2006 to 2025 (in million U.S. dollars) [Graph], AstraZeneca, & U.S. Securities and Exchange Commission, February 18, 2026. [Online]. Available: /statistics/266545/astrazenecas-revenue-from-top-product-nexium-since-2006/
